Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibrin Fibrinogen Degradation Products | 6 | 2018 | 9 | 1.320 |
Why?
|
| Emergency Service, Hospital | 9 | 2018 | 245 | 1.310 |
Why?
|
| Pulmonary Embolism | 6 | 2011 | 51 | 0.820 |
Why?
|
| Fibrinolytic Agents | 3 | 2018 | 55 | 0.650 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 35 | 0.560 |
Why?
|
| Colonoscopy | 3 | 2020 | 72 | 0.530 |
Why?
|
| Emergency Medicine | 4 | 2015 | 92 | 0.510 |
Why?
|
| Medical Overuse | 1 | 2015 | 6 | 0.490 |
Why?
|
| Health Policy | 1 | 2015 | 35 | 0.480 |
Why?
|
| African Americans | 1 | 2014 | 1 | 0.450 |
Why?
|
| Premenopause | 1 | 2014 | 10 | 0.440 |
Why?
|
| Postmenopause | 1 | 2014 | 51 | 0.440 |
Why?
|
| Duodenal Diseases | 1 | 2013 | 2 | 0.420 |
Why?
|
| Vascular Fistula | 1 | 2013 | 2 | 0.420 |
Why?
|
| Abdominal Pain | 1 | 2013 | 4 | 0.420 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 4 | 0.420 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 7 | 0.420 |
Why?
|
| Exercise | 1 | 2014 | 399 | 0.340 |
Why?
|
| Enema | 1 | 2010 | 3 | 0.330 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 38 | 0.330 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 71 | 0.310 |
Why?
|
| Humans | 25 | 2020 | 24703 | 0.290 |
Why?
|
| Critical Pathways | 1 | 2007 | 17 | 0.270 |
Why?
|
| Ischemic Attack, Transient | 1 | 2007 | 17 | 0.270 |
Why?
|
| Enterobius | 1 | 2006 | 1 | 0.250 |
Why?
|
| Enterobiasis | 1 | 2006 | 1 | 0.250 |
Why?
|
| Cecum | 1 | 2006 | 11 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 87 | 0.250 |
Why?
|
| Adult | 8 | 2018 | 7255 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 244 | 0.200 |
Why?
|
| Sensitivity and Specificity | 6 | 2009 | 437 | 0.190 |
Why?
|
| Middle Aged | 10 | 2017 | 8294 | 0.190 |
Why?
|
| Aged | 8 | 2014 | 8382 | 0.180 |
Why?
|
| Health Services Research | 3 | 2015 | 37 | 0.170 |
Why?
|
| Male | 12 | 2020 | 13669 | 0.170 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 7 | 0.170 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 44 | 0.160 |
Why?
|
| Gastroenterology | 1 | 2020 | 9 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2014 | 370 | 0.160 |
Why?
|
| Age Factors | 3 | 2018 | 728 | 0.160 |
Why?
|
| Female | 11 | 2020 | 14048 | 0.150 |
Why?
|
| Telephone | 1 | 1997 | 26 | 0.140 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 64 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 1997 | 16 | 0.140 |
Why?
|
| Aftercare | 1 | 1997 | 21 | 0.140 |
Why?
|
| Knowledge | 2 | 2007 | 14 | 0.140 |
Why?
|
| Diffusion of Innovation | 2 | 2007 | 21 | 0.140 |
Why?
|
| Feasibility Studies | 3 | 2020 | 196 | 0.140 |
Why?
|
| Risk Factors | 4 | 2018 | 2099 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 9 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 24 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 24 | 0.140 |
Why?
|
| Prebiotics | 1 | 2017 | 18 | 0.130 |
Why?
|
| Time Factors | 2 | 2015 | 1327 | 0.120 |
Why?
|
| Environment | 1 | 2015 | 38 | 0.120 |
Why?
|
| Clinical Decision-Making | 1 | 2015 | 41 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 40 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 76 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2008 | 532 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 613 | 0.120 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 2 | 0.110 |
Why?
|
| E-Selectin | 1 | 2014 | 2 | 0.110 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2014 | 3 | 0.110 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 5 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 105 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 34 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 35 | 0.110 |
Why?
|
| Triglycerides | 1 | 2014 | 51 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2020 | 1612 | 0.110 |
Why?
|
| Physical Fitness | 1 | 2014 | 42 | 0.110 |
Why?
|
| Cholesterol | 1 | 2014 | 58 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2014 | 56 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2014 | 93 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 11 | 0.100 |
Why?
|
| Gastrointestinal Transit | 1 | 2012 | 12 | 0.100 |
Why?
|
| Capsule Endoscopy | 1 | 2012 | 5 | 0.100 |
Why?
|
| Intestine, Small | 1 | 2012 | 29 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 315 | 0.100 |
Why?
|
| Headache | 1 | 2012 | 33 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2014 | 421 | 0.090 |
Why?
|
| Medicare | 1 | 2012 | 111 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2010 | 6 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 149 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 314 | 0.080 |
Why?
|
| Antifibrinolytic Agents | 1 | 2009 | 17 | 0.080 |
Why?
|
| Resuscitation | 1 | 2008 | 11 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2020 | 112 | 0.070 |
Why?
|
| Cause of Death | 1 | 2008 | 56 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2008 | 36 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2008 | 121 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2007 | 18 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 44 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sepsis | 1 | 2008 | 110 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2010 | 1042 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2006 | 20 | 0.070 |
Why?
|
| Calcitonin | 1 | 2006 | 14 | 0.070 |
Why?
|
| ROC Curve | 2 | 2008 | 131 | 0.070 |
Why?
|
| Recurrence | 1 | 2007 | 281 | 0.060 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2005 | 3 | 0.060 |
Why?
|
| Bacteremia | 1 | 2006 | 97 | 0.060 |
Why?
|
| Heparin | 1 | 2005 | 21 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 29 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 75 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 303 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2005 | 87 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 52 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2007 | 199 | 0.060 |
Why?
|
| Stroke | 1 | 2007 | 254 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2010 | 3208 | 0.050 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2003 | 2 | 0.050 |
Why?
|
| Critical Illness | 1 | 2005 | 106 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 412 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2003 | 61 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2020 | 198 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 4509 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2001 | 41 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2001 | 66 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 14 | 0.040 |
Why?
|
| Learning Curve | 1 | 2020 | 17 | 0.040 |
Why?
|
| Physicians | 1 | 2001 | 103 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2001 | 151 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 1748 | 0.040 |
Why?
|
| Animals | 1 | 2006 | 3330 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 1998 | 4 | 0.040 |
Why?
|
| United States | 3 | 2012 | 1873 | 0.040 |
Why?
|
| Michigan | 1 | 1997 | 17 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 1997 | 14 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1997 | 29 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 101 | 0.030 |
Why?
|
| Fermentation | 1 | 2017 | 12 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 16 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 25 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 37 | 0.030 |
Why?
|
| Feces | 1 | 2017 | 77 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 116 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 367 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 6 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 192 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 33 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 123 | 0.030 |
Why?
|
| Communication | 1 | 2015 | 96 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 304 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 571 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2012 | 3156 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 21 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 365 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 112 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2012 | 118 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 47 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 598 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 26 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 95 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2008 | 59 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 231 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 117 | 0.020 |
Why?
|
| Critical Care | 1 | 2008 | 112 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 250 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 52 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 1992 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 11 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 158 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 202 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2006 | 251 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 814 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 411 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 285 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 611 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 1539 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 1847 | 0.010 |
Why?
|
| Child | 1 | 2006 | 1131 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2001 | 41 | 0.010 |
Why?
|
| Data Collection | 1 | 2001 | 86 | 0.010 |
Why?
|
| Quality of Life | 1 | 2001 | 541 | 0.010 |
Why?
|